PASITHEA THERAPEUTICS CORP. Employee Benefits and Share-based Compensation
PASITHEA THERAPEUTICS CORP. (KTTA) reported Employee Benefits and Share-based Compensation of $581.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2023-08-11
- PASITHEA THERAPEUTICS CORP. employee benefits and share-based compensation for the quarter ending 2023-06-30 was -$195.00K, a 295.00% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. employee benefits and share-based compensation for the quarter ending 2023-03-31 was $776.00K, a 703.06% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. employee benefits and share-based compensation for the quarter ending 2022-12-31 was $140.00K, a 25.00% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. employee benefits and share-based compensation for the quarter ending 2022-09-30 was $100.00K.
- PASITHEA THERAPEUTICS CORP. employee benefits and share-based compensation for fiscal 2022 was $440.00K, a 209.86% increase from fiscal 2021.
- PASITHEA THERAPEUTICS CORP. employee benefits and share-based compensation for fiscal 2021 was $142.00K.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$195.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $581.00K 10-Q · filed 2023-08-11 | $721.00K derived: sum of 3 quarters · filed 2023-08-11 | $821.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | $776.00K 10-Q · filed 2023-05-12 | $916.00K derived: sum of 2 quarters · filed 2023-05-12 | $1.02M derived: sum of 3 quarters · filed 2023-05-12 | $1.12M derived: sum of 4 quarters · filed 2023-05-12 |
| 2022-12-31 | $140.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $240.00K derived: sum of 2 quarters · filed 2023-03-30 | $340.00K derived: sum of 3 quarters · filed 2023-03-30 | $440.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $100.00K 10-Q · filed 2022-11-14 | $200.00K derived: sum of 2 quarters · filed 2022-11-14 | $300.00K 10-Q · filed 2022-11-14 | $408.63K derived: sum of 4 quarters · filed 2023-03-30 |
| 2022-06-30 | $100.00K 10-Q · filed 2022-08-15 | $200.00K 10-Q · filed 2022-08-15 | $308.63K derived: sum of 3 quarters · filed 2023-03-30 | $38.63K derived: sum of 4 quarters · filed 2023-03-30 |
| 2022-03-31 | $96.63K 10-Q · filed 2022-05-16 | $208.63K derived: sum of 2 quarters · filed 2023-03-30 | -$61.37K derived: sum of 3 quarters · filed 2023-03-30 | $238.63K derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$158.00K derived: sum of 2 quarters · filed 2023-03-30 | $142.00K derived: sum of 3 quarters · filed 2023-03-30 | $142.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$270.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $30.00K derived: sum of 2 quarters · filed 2022-11-14 | $30.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $300.00K 10-Q · filed 2022-08-15 | $300.00K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |